Loading
Total declarations
Companies
▲ Purchases (22 ops.)
▼ Sales (5 ops.)
Latest filing published 11 Sept 2026 for Travere Therapeutics, Inc., €150k.
Filing timeline
BuySaleJeffrey A. Meckler
Insider track record
Disclosed buys
22
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-28.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jeffrey A. Meckler: trading record in brief
Filings by Jeffrey A. Meckler span 5 companies, the busiest being Travere Therapeutics, Inc., Indaptus Therapeutics, Inc. and QLT Inc/BC. Between 3 May 2013 and 10 September 2026, the trades on record add up to 51 filings.
On the open market, the record shows 22 purchases worth €1.3M and 5 sales worth €1.7M. Sales outweigh purchases by €410k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 16 share grants and 8 option exercises. So far in 2026, the count stands at no purchases and 4 sales.
The median purchase comes to €51k. Of 13 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 11 September 2026: an open-market sale of €181k, in Travere Therapeutics, Inc. The last purchase on record was published on 22 November 2022, which is 1,432 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey A. Meckler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
10,000 shares@ US$17.44Common StockSEC:0001506916-26-000004:0
10,000 shares@ US$26.52Common StockSEC:0001506916-26-000004:1
1,700 shares@ US$65.3917Common StockSEC:0001506916-26-000004:2
1,200 shares@ US$66.15Common StockSEC:0001506916-26-000004:3
14,000 shares@ US$67.4634Common StockSEC:0001506916-26-000004:4
3,100 shares@ US$68.088Common StockSEC:0001506916-26-000004:5
216,617 shares@ US$2.0345.9% of flowCommon StockSEC:0001493152-25-029355:0
6,068 shares@ US$8.30249.7% of flowCommon StockSEC:0001641172-25-021376:0
6,500 shares0Common StockSEC:0001415889-25-013500:0
42,553 shares@ US$1.1759.0% of flowCommon stockSEC:0001493152-24-047808:0
40,000 shares@ US$10.48100.0% of flowCommon StockSEC:0001415889-24-024117:0
84,932 shares@ US$1.82526.9% of flowCommon stockSEC:0001493152-24-030839:0
6,500 shares0Common StockSEC:0001415889-24-012848:0
4,500 shares0Common StockSEC:0001209191-23-030961:0
400 shares@ US$1.76370.1% of flowCommon stockSEC:0001493152-22-033241:0
Canonical exit: 16 Feb 2023 (T+90)
10,308 shares@ US$2.805.5% of flowCommon stockSEC:0001493152-22-025578:0
Canonical exit: 7 Dec 2022 (T+90)
1,060 shares@ US$2.440.5% of flowCommon stockSEC:0001493152-22-025319:0
Canonical exit: 5 Dec 2022 (T+90)
19,727 shares@ US$2.635.9% of flowCommon stockSEC:0001493152-22-016027:0
Canonical exit: 4 Sept 2022 (T+90)
3,000 shares0Common StockSEC:0001209191-22-028697:0
11,187 shares@ US$5.827.0% of flowCommon StockSEC:0001493152-21-029297:0
Canonical exit: 16 Feb 2022 (T+90)
12,000 shares@ US$7.008.7% of flowCommon StockSEC:0001493152-21-022936:0
Canonical exit: 13 Dec 2021 (T+90)
3,000 shares0Common StockSEC:0001209191-21-033849:0
22 of 22 declarations
